作者:David J. Rawson、Delphine Brugier、Anthony Harrison、Jo Hough、Julie Newman、Joe Otterburn、Graham N. Maw、Jenny Price、Lisa R. Thompson、Paul Turnpenny、Andrew N. Warren
DOI:10.1016/j.bmcl.2011.04.056
日期:2011.6
Conformational constraint has been used to design a potent series of alpha(2)delta ligands derived from the readily available starting material (2S,4R)-hydroxy-L-proline. The ligands have improved physicochemistry and potency compared to their linear counterparts (described in our earlier publication) and the lead compound has been progressed to clinical development. (C) 2011 Elsevier Ltd. All rights reserved.